SGLT-2 inhibitors may primarily drive growth of branded heart failure treatment market: GlobalData Read more
EMA approves label update for Takeda’s HYQVIA, expands use to treat secondary immunodeficiencies Read more
Baricitinib in combination with remdesivir reduces recovery time in hospitalised COVID-19 patients: Study Read more
US FDA denies approval to Mallinckrodt for Terlipressin to treat Hepatorenal Syndrome Type 1 Read more